Factors impacting valuation of biopharma companies per executives 2020

Published by
Matej Mikulic,
May 27, 2021
According to a survey conducted in 2020, 61 percent of surveyed U.S. biopharma executives stated that competition for innovation on high-value assets had a high impact on valuations. This statistic illustrates the factors impacting valuation changes of biopharmaceutical companies worldwide according to U.S. biopharma executives.

Factors impacting valuation changes of biopharmaceutical companies according to U.S. executives in 2020

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2021

Region

United States

Survey time period

2020

Number of respondents

30 respondents

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus (COVID-19) in Japan "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus (COVID-19) in Japan

Overview

6

Cases by prefecture

4

Vaccination

4

Economic impact

4

Government measures

5

Affected business

6

Bankruptcy and dismissal

6

Public opinion

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus (COVID-19) in JapanPharmaceutical industry in JapanTravel and tourism industry in JapanHealth care in JapanHospitals in Japan
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.